We invite boys and girls 6 to 17 years of age to see if they qualify for this study. The primary purpose of this research study is to determine the safety, tolerability and effectiveness of an investigational medication for Tourette's Syndrome.
Each child will be evaluated to determine his or her eligibility to participate in the research study. Each patient who qualifies will receive either the investigational medication or placebo (inactive substance), study-related medical exams, and study-related laboratory tests at no cost. Compensation for time and travel may also be available.
To learn more about this study, call our office at (800) NEW-STUDY or visit our website at www.Syrentis.com